Skip to main content
. 2025 Aug 19;16:1619611. doi: 10.3389/fmicb.2025.1619611

Table 2.

Outcomes of the study population (n = 155).

Variable n (%)
Admitted to ICU 64 (41.3)
Relapse within 30 days 32 (20.7)
Acute kidney injury 56 (36.1)
Microbiological eradication 88 (56.8)
Death within 90 days of the first culture 53 (34.2)
CRE Attributable mortalityb 36 (67.9)
Clinical cure 115 (74.2)

ICU, intensive care unit; CRE, Carbapenem-resistant Enterobacterales.

b

Out of 53 patients who died.